Advances in plant molecular farming

作者：Obembe Olawole O^*; Popoola Jacob O; Leelavathi Sadhu; Reddy Siva V

来源：Biotechnology Advances, 2011, 29(2): 210-222.

DOI：10.1016/j.biotechadv.2010.11.004

• Plant-derived proteins
• Clinical development
• Commercialization
• Biosafety
• Regulation

Plant molecular farming (PMF) is a new branch of plant biotechnology, where plants are engineered to produce recombinant pharmaceutical and industrial proteins in large quantities. As an emerging subdivision of the biopharmaceutical industry. PMF is still trying to gain comparable social acceptance as the already established production systems that produce these high valued proteins in microbial, yeast, or mammalian expression systems. This article reviews the various cost-effective technologies and strategies, which are being developed to improve yield and quality of the plant-derived pharmaceuticals, thereby making plant-based production system suitable alternatives to the existing systems. It also attempts to overview the different novel plant-derived pharmaceuticals and non-pharmaceutical protein products that are at various stages of clinical development or commercialization. It then discusses the biosafety and regulatory issues, which are crucial (if strictly adhered to) to eliminating potential health and environmental risks, which in turn is necessary to earning favorable public perception, thus ensuring the success of the industry.

• 出版日期2011-4